0001795036-20-000001.txt : 20200827 0001795036-20-000001.hdr.sgml : 20200827 20200827140248 ACCESSION NUMBER: 0001795036-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: 4a5 FILED AS OF DATE: 20200827 DATE AS OF CHANGE: 20200827 EFFECTIVENESS DATE: 20200827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xcellerate Biotech, Inc. CENTRAL INDEX KEY: 0001795036 IRS NUMBER: 843483025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-374274 FILM NUMBER: 201141469 BUSINESS ADDRESS: STREET 1: 1701 PENNSYLVANIA AVE. NW STREET 2: SUITE 300 CITY: WASHINGTON STATE: DC ZIP: 20036 BUSINESS PHONE: 240-620-2394 MAIL ADDRESS: STREET 1: 1701 PENNSYLVANIA AVE. NW STREET 2: SUITE 300 CITY: WASHINGTON STATE: DC ZIP: 20036 D 1 primary_doc.xml X0708 D LIVE 0001795036 Xcellerate Biotech, Inc. 13212 Valley Drive Rockville MD MARYLAND 20850 240-620-2394 DELAWARE None None Corporation true 2019 Peter Dolan 13212 Valley Drive Rockville MD MARYLAND 20850 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b 4a5 false 2020-08-18 false true false 718782 718782 718782 0 false 1 0 0 0 false Xcellerate Biotech, Inc. /s/ Peter Dolan Peter Dolan President 2020-08-27